Major countries covered in the AI-based Clinical Trials Solution Provider Market report include Germany, UK, France, Italy, Spain, Russia, U.S., Canada, Mexico, Brazil, Argentina, China, Japan, India, South Korea, Israel, GCC countries, South Africa, Turkey, etc.

Isle of Man, UK, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Douglas Insights has further expanded its comparison engine with AI-based Clinical Trials Solution Provider Market research reports, allowing market researchers, analysts, industry experts, and businesses to identify market trends, drivers of growth, limitations, obstacles, and predictions. Douglas Insights is the world's first comparison engine for market research reports. With access to the extensive range of private and public market reports, the digital tool lets researchers compare various reports by Publisher Rating, Table of Contents, Date of Publication, and Price.

It takes a lot of effort and money to correctly develop a unique treatment technique. In reality, it is predicted that it takes a prescription medication about a decade and more than USD 2.5 billion in investment capital before it is commercially available. Clinical trials are a vital criterion in this system because they allow regulators and innovators to evaluate a proposed drug's effectiveness and determine if it is ready for human consumption.

Clinical trials are believed to take up close to 50% of the overall time and financial resources used during the medication development process, with many resulting in failures and huge losses in both finance and time.

To overcome these challenges, biotech companies and pharmaceuticals are employing AI in their R&D endeavours to reduce expenses, enhance data quality, decrease trial lengths, and cut costs. AI technologies are growing in demand for clinical trials as they improve efficiency, streamline clinical practice procedures, and find new medicines and treatments more quickly and affordably. The demand for AI-based clinical trial solution providers is anticipated to rise significantly as a result in the future.

Compare the reports on AI-based Clinical Trials Solution Provider Market- https://douglasinsights.com/ai-based-clinical-trials-solution-provider-market

The highest market share is held by the oncology sector for AI-based clinical trials, with an anticipated compound annual growth rate of over 25.8% in the following decade.

Increasing government and corporate efforts to upgrade medical facilities by using cutting-edge AI technology and medications are the key elements propelling the market for providers of AI-based clinical trial solutions.

The North American region currently holds the lion's share of the market with increasing investment from the corporate world as well as the growing use of cutting-edge technologies like deep learning in clinical trials, machine learning, and artificial intelligence. The second-highest market share belongs to the European regions, followed by South East Asian regions.

By enhancing patient retention and enrolment, improving protocol architecture, and facilitating the creation of medical products, AI technology and big data are predicted to boost clinical trial effectiveness and speed up the development of the global AI-based clinical trials solution provider market.

However, one key factor that is anticipated to restrain the market expansion for AI-based clinical trials solution providers to some amount over the projected timeframe is the strict rules related to the authorisation of AI-based clinical testing.

A few notable industry players are Antidote Technologies Inc., Concentro Health AI, BioAge Labs Inc., Owkin Inc., Unlearn.AI, Inc., LLC, Saama Technologies Inc., IBM, Deep 6 AI Inc., AiCure, and PathAI Inc.

Saama Technologies Inc. and Oracle signed an agreement in March 2021 to integrate with Saama's smart apps the Oracle's Clinical One Platform for Health Science. This will allow for quicker results from clinical studies and immediate analytics for investigators and practitioners. This agreement will also strengthen Saama's position as a provider of AI-driven Intelligent Clinical Cloud solutions.

Multiple organisations in the international market for providers of solutions for AI-based clinical trials are making significant investments in R & D. The shift is helping them with the tasks related to new product innovation and, ultimately, the launch of new products. The market for providers of AI-based clinical trial solutions is anticipated to grow at a promising rate in the upcoming years as a result of these trends.

Compare the reports on AI-based Clinical Trials Solution Provider Market- https://douglasinsights.com/ai-based-clinical-trials-solution-provider-market

The detailed segments and sub-segment of the market are explained below:

By Clinical Trial Phase:

• Phase-I
• Phase-II
• Phase-III

By Application:

• Oncology
• Cardiovascular Diseases
• Neurological Diseases or Conditions
• Infectious Diseases
• Others

By End-use:

• Pharmaceutical Companies
• Academia
• Others

By Region:

North America

• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific

• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America

• Brazil
• Mexico
• Rest of the World

Frequently Asked Questions

Can i create custom Project on AI-based Clinical Trials Solution Provider Market?

Yes you can create custom project on AI-based Clinical Trials Solution Provider Market based on your budget and scope.

How to Compare Table of Contents of AI-based Clinical Trials Solution Provider Market Reports?

You can select three reports on AI-based Clinical Trials Solution Provider Market to compare Table of Contents.

How to find best report on AI-based Clinical Trials Solution Provider Market?

 

You can compare AI-based Clinical Trials Solution Provider Market Reports by table of contents, price, number of pages, Publisher rating and published date. it will help you to finalize best report on AI-based Clinical Trials Solution Provider Market.

Compare the reports on AI-based Clinical Trials Solution Provider Market- https://douglasinsights.com/ai-based-clinical-trials-solution-provider-market

About Douglas Insights:

Douglas Insights UK limited is first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions.

Related Comparisions:
Clinical Trials Market- https://douglasinsights.com/clinical-trials-market-1
In Silico Clinical Trials Market- https://douglasinsights.com/in-silico-clinical-trials-market
Intelligent Clinical Trials Market- https://douglasinsights.com/intelligent-clinical-trials-market
Clinical Trials Management System (CTMS) Market- https://douglasinsights.com/clinical-trials-management-system-ctms-market
Clinical Trial Supplies Market- https://douglasinsights.com/clinical-trial-supplies-market
Clinical Trial Management Systems Market- https://douglasinsights.com/clinical-trial-management-systems-market

Office-
Bridge House, W Baldwin Rd,
Isle of Man IM4 5HA, Isle of Man
Email- isabella@douglasinsights.com
Telephone - +44 7624 248772
Web- douglasinsights.com/

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.